Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT ID: NCT01649674
Last Updated: 2023-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
525 participants
INTERVENTIONAL
2011-11-30
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy
NCT01603654
A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate
NCT01778192
Comparison Between Coolprep and Picolyte for Bowel Cleansing
NCT01774175
Sodium Picosulfate Plus Magnesium Citrate Versus Macrogol 4000 in the Bowel Cleansing Procedure: a Comparison of Efficiency and Compatibility
NCT01607099
Split Dose Pico-Salax + Bisacodyl vs. PEG Split Dose
NCT01415687
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PEG
polyethylene glycol solution 2 liters
polyethylene glycole (PEG) solution
NapP
Sodium picosulphate and magnesium citrate solution 300 ml
sodium picosulphate and magnesium citrate solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
polyethylene glycole (PEG) solution
sodium picosulphate and magnesium citrate solution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
* Age \> 18 years
Exclusion Criteria
* Severe inflammatory bowel disease (IBD)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Naples
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valentina D'Angelo, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Mario de Bellis, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Presidio Ospedaliero Villa d'Agri
Marsicovetere, , Italy
AO Fatebenefratelli ed Oftalmico
Milan, , Italy
A.O.U. Seconda Universita di Napoli
Napoli, , Italy
Clinica Mediterranea
Napoli, , Italy
Istituto Nazionale dei Tumori
Napoli, , Italy
Presidio Ospedaliero Ascalesi
Napoli, , Italy
Presidio Ospedaliero Maresca
Torre del Greco, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
D'Angelo V, Piccirillo MC, Di Maio M, Gallo C, Bucci C, Civiletti C, Di Girolamo E, Marone P, Rossi GB, Tempesta AM, Tracey MC, Romano M, Miranda A, Taranto D, Sessa G, Esposito P, Salerno R, Pumpo R, De Filippo FR, Della Valle E, de Bellis M, Perrone F. A multicenter randomized phase 4 trial comparing sodium picosulphate plus magnesium citrate vs. polyethylene glycol plus ascorbic acid for bowel preparation before colonoscopy. The PRECOL trial. Front Med (Lausanne). 2022 Dec 8;9:1013804. doi: 10.3389/fmed.2022.1013804. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-000587-10
Identifier Type: REGISTRY
Identifier Source: secondary_id
PRECOL2011-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.